OVERESTIMATION OF RENAL-FUNCTION IN GLUCOCORTICOSTEROID TREATED PATIENTS

被引：37

作者：

HORBER, FF ^{[1
]}

SCHEIDEGGER, J ^{[1
]}

FREY, FJ ^{[1
]}

机构：

[1] UNIV BERN, DEPT DIAGNOST RADIOL, MED POLIKLIN, FREIBURGSTR 3, CH-3010 BERN, SWITZERLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 28卷 / 05期

关键词：

D O I：

10.1007/BF00544064

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：537 / 541

页数：5

共 23 条

[1] USE OF SERUM CREATININE CONCENTRATIONS TO DETERMINE RENAL-FUNCTION [J].

BJORNSSON, TD .

CLINICAL PHARMACOKINETICS, 1979, 4 (03) :200-222

[2] CREATINE AND MUSCULAR DYSTROPHY - RELATIONSHIP OF CREATINE-CREATININE METABOLISM TO DIET AND DRUGS [J].

BOURDAKOS, NG ;

WOLF, S .

ARCHIVES OF NEUROLOGY, 1962, 6 (06) :439-&

[3]

Burger M., 1919, Z GES EXP MED, V9, P361

[4] DECREASED RATE OF CREATININE PRODUCTION IN PATIENTS WITH HEPATIC-DISEASE - IMPLICATIONS FOR ESTIMATION OF CREATININE CLEARANCE [J].

COCCHETTO, DM ;

TSCHANZ, C ;

BJORNSSON, TD .

THERAPEUTIC DRUG MONITORING, 1983, 5 (02) :161-168

[5] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[6] INDIVIDUALIZATION OF DRUG DOSAGE IN PATIENTS WITH RENAL-DISEASE [J].

DETTLI, L .

MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) :977-985

[7]

GOLDMAN R, 1954, P SOC EXP BIOL MED, V85, P446

[8] QUANTIFICATION OF BODY-FAT DISTRIBUTION IN THE ABDOMEN USING COMPUTED-TOMOGRAPHY [J].

GRAUER, WO ;

MOSS, AA ;

CANN, CE ;

GOLDBERG, HI .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 1984, 39 (04) :631-637

[9]

GRAYSTONE JE, 1968, HUMAN GROWTH BODY CO, V12, P182

[10] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE CONCENTRATION BASED ON LEAN BODY-MASS [J].

HALLYNCK, T ;

SOEP, HH ;

THOMIS, J ;

BOELAERT, J ;

DANEELS, R ;

FILLASTRE, JP ;

DEROSA, F ;

RUBINSTEIN, E ;

HATALA, M ;

SPOUSTA, J ;

DETTLI, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (03) :414-421

← 1 2 3 →